ATE131829T1 - Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke - Google Patents
Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zweckeInfo
- Publication number
- ATE131829T1 ATE131829T1 AT89912256T AT89912256T ATE131829T1 AT E131829 T1 ATE131829 T1 AT E131829T1 AT 89912256 T AT89912256 T AT 89912256T AT 89912256 T AT89912256 T AT 89912256T AT E131829 T1 ATE131829 T1 AT E131829T1
- Authority
- AT
- Austria
- Prior art keywords
- peptides
- submaxillar
- glands
- diagnostics
- determinations
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1021—Tetrapeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8813353A FR2637600B1 (fr) | 1988-10-11 | 1988-10-11 | Peptides et polypeptides provenant de la glande sous maxillaire du rat, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et applications de ces produits au diagnostic, a la detection ou a des fins therapeutiques |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE131829T1 true ATE131829T1 (de) | 1996-01-15 |
Family
ID=9370902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT89912256T ATE131829T1 (de) | 1988-10-11 | 1989-10-11 | Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke |
Country Status (7)
Country | Link |
---|---|
US (4) | US5859189A (de) |
EP (1) | EP0394424B1 (de) |
JP (1) | JP2980334B2 (de) |
AT (1) | ATE131829T1 (de) |
DE (1) | DE68925199T2 (de) |
FR (1) | FR2637600B1 (de) |
WO (1) | WO1990003981A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6589750B2 (en) | 1997-02-20 | 2003-07-08 | Institut Pasteur | Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives |
AU6154700A (en) * | 1999-06-23 | 2001-01-31 | Centre National De La Recherche Scientifique (C.N.R.S.) | Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
ES2235806T3 (es) * | 2000-12-22 | 2005-07-16 | Institut Pasteur | Procedimiento de seleccion de moleculas ligando que se unen especificamente al sitio de union nep para el prentapeptido qhnpr. |
EP1577320B1 (de) | 2004-03-19 | 2012-07-18 | Institut Pasteur | Von humanen BPLP Proteinen abgeleitete Peptide, deren kodierende Polynukleotide und Antikörper gegen besagte Peptide |
US7190757B2 (en) * | 2004-05-21 | 2007-03-13 | Analogic Corporation | Method of and system for computing effective atomic number images in multi-energy computed tomography |
US7136450B2 (en) * | 2004-05-26 | 2006-11-14 | Analogic Corporation | Method of and system for adaptive scatter correction in multi-energy computed tomography |
US7415147B2 (en) * | 2004-06-04 | 2008-08-19 | Analogic Corporation | Method of and system for destreaking the photoelectric image in multi-energy computed tomography |
US7327853B2 (en) * | 2004-06-09 | 2008-02-05 | Analogic Corporation | Method of and system for extracting 3D bag images from continuously reconstructed 2D image slices in computed tomography |
US7302083B2 (en) * | 2004-07-01 | 2007-11-27 | Analogic Corporation | Method of and system for sharp object detection using computed tomography images |
US7224763B2 (en) * | 2004-07-27 | 2007-05-29 | Analogic Corporation | Method of and system for X-ray spectral correction in multi-energy computed tomography |
US7388983B2 (en) * | 2004-08-18 | 2008-06-17 | Analogic Corporation | Method of and system for detecting anomalies in projection images generated by computed tomography scanners |
US7136451B2 (en) * | 2004-10-05 | 2006-11-14 | Analogic Corporation | Method of and system for stabilizing high voltage power supply voltages in multi-energy computed tomography |
US8009883B2 (en) * | 2007-02-09 | 2011-08-30 | Analogic Corporation | Method of and system for automatic object display of volumetric computed tomography images for fast on-screen threat resolution |
US7724866B2 (en) * | 2007-06-27 | 2010-05-25 | Analogic Corporation | Method of and system for variable pitch computed tomography scanning for baggage screening |
US20110227910A1 (en) | 2008-03-27 | 2011-09-22 | Analogic Corporation | Method of and system for three-dimensional workstation for security and medical applications |
RU2542365C2 (ru) * | 2008-04-07 | 2015-02-20 | Энститю Пастёр | Производные опиорфинного пептида как потенциальные ингибиторы эктопептидаз, участвующих в деградации энкефалинов |
FR2931362B1 (fr) | 2008-05-26 | 2017-08-18 | Pasteur Institut | L'opiorphine pour une utilisation en tant que psychostimulant. |
CA2645452A1 (en) * | 2008-11-28 | 2010-05-28 | Institut Pasteur | Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56145222A (en) * | 1980-04-28 | 1981-11-11 | Toshiyuki Hamaoka | Improved antibody and its preparation |
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
DE3374170D1 (en) * | 1982-05-06 | 1987-12-03 | Massachusetts Inst Technology | Production of enterovirus neutralizing antibodies from vp1 |
CA1252046A (en) * | 1982-11-04 | 1989-04-04 | Martin J. Cline | Methods for oncogenic detection |
US4699877A (en) * | 1982-11-04 | 1987-10-13 | The Regents Of The University Of California | Methods and compositions for detecting human tumors |
GB8327966D0 (en) * | 1983-10-19 | 1983-11-23 | Nyegaard & Co As | Chemical compounds |
US4669877A (en) * | 1985-02-22 | 1987-06-02 | The Perkin-Elmer Corporation | Digital gain controlled current to voltage amplifier |
US4886747A (en) * | 1985-03-22 | 1989-12-12 | Genentech, Inc. | Nucleic acid encoding TGF-β and its uses |
FI100106B (fi) * | 1986-12-05 | 1997-09-30 | Novartis Ag | Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi |
-
1988
- 1988-10-11 FR FR8813353A patent/FR2637600B1/fr not_active Expired - Fee Related
-
1989
- 1989-10-11 AT AT89912256T patent/ATE131829T1/de not_active IP Right Cessation
- 1989-10-11 WO PCT/FR1989/000523 patent/WO1990003981A1/fr active IP Right Grant
- 1989-10-11 EP EP89912256A patent/EP0394424B1/de not_active Expired - Lifetime
- 1989-10-11 JP JP1511369A patent/JP2980334B2/ja not_active Expired - Lifetime
- 1989-10-11 DE DE68925199T patent/DE68925199T2/de not_active Expired - Lifetime
-
1993
- 1993-11-17 US US08/153,277 patent/US5859189A/en not_active Expired - Lifetime
-
1995
- 1995-06-07 US US08/476,120 patent/US6025143A/en not_active Expired - Lifetime
-
1999
- 1999-08-31 US US09/386,850 patent/US6916607B2/en not_active Expired - Fee Related
-
2004
- 2004-12-03 US US11/002,458 patent/US20050153374A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPH03501738A (ja) | 1991-04-18 |
US5859189A (en) | 1999-01-12 |
DE68925199T2 (de) | 1996-09-05 |
WO1990003981A1 (fr) | 1990-04-19 |
JP2980334B2 (ja) | 1999-11-22 |
FR2637600B1 (fr) | 1992-03-06 |
US6025143A (en) | 2000-02-15 |
EP0394424B1 (de) | 1995-12-20 |
US20050153374A1 (en) | 2005-07-14 |
EP0394424A1 (de) | 1990-10-31 |
FR2637600A1 (fr) | 1990-04-13 |
US20030170620A1 (en) | 2003-09-11 |
DE68925199D1 (de) | 1996-02-01 |
US6916607B2 (en) | 2005-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE131829T1 (de) | Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke | |
LU91087I2 (fr) | Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base. | |
DK0573545T3 (da) | Monoklonale antistoffer mod receptor-inducerede bindingssteder | |
ATE98376T1 (de) | Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung. | |
DK0737208T3 (da) | Monoklonale antistoffer, der er specifikke for PHF-tau, hybridomaer, der secernerer dem, og antigen-genkendelse for disse antistoffer og deres anvendelsesmuligheder | |
ATE177758T1 (de) | Synthetische peptide, antikörper dagegen und ihre verwendung | |
AU564620B2 (en) | Peptides and protein-peptide complexes | |
ES8802457A1 (es) | Un procedimiento para la preparacion de polipeptidos inmunogenicos | |
Mole et al. | The isolation and characterization of the VH domain from rabbit heavy chains of different a locus allotype | |
ES489522A0 (es) | Un procedimiento para la preparacion de un polipeptido | |
FI103975B1 (fi) | Immunodiagnostinen nivelreumakoe | |
ATE161543T1 (de) | Aminoterminale prokollagen 1(i) peptide | |
Bubb et al. | Studies on the structural and biological functions of the Cμ3 and Cμ4 domains of IgM | |
ATE317851T1 (de) | Polypeptide mit aminosäuresequenzen aus dem n- terminalen bereich von gp116 von cytomegalovirus und deren verwendung bei der diagnostik, prophylaxe und therapie | |
Day et al. | Format determinants of synthetic myelin basic protein peptide S82 mimicked by a mixture of synthetic peptides S8 and S79 | |
Williams et al. | Immunity in the Connective Tissue Diseases | |
Campbell | THE CLEAVAGE OF RABBIT IMMUNOGLOBULIN-G AT CONSTANT TRYPTOPHAN RESIDUES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
EELA | Cancelled due to lapse of time |